Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -44.73% is 66% below its 5-year average of -27.03%, near the low end of its 5-year range (-50.10%–-6.44%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.17% below its 12-month average of -42.94%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -44.73%.
RETURN ON INVESTED CAPITAL (ROIC)
-44.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-42.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-34.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-27.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-4.17%
CURRENT VS 3Y AVG
-30.39%
CURRENT VS 5Y AVG
-65.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-25.43%
vs the sector median at left
Tyra Biosciences, Inc.
Market Cap
$1.21B
Return on Invested Capital (ROIC)
-44.73%
TTM Avg
-42.94%
3Y Avg
-34.30%
5Y Avg
-27.03%
Market Cap
$1.21B
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-57.11%
3Y Avg
-57.11%
5Y Avg
-57.11%
Market Cap
$1.20B
Return on Invested Capital (ROIC)
-52.44%
TTM Avg
-96.82%
3Y Avg
-100.85%
5Y Avg
-77.97%
Market Cap
$1.22B
Return on Invested Capital (ROIC)
9.48%
TTM Avg
1.29%
3Y Avg
-3.62%
5Y Avg
0.10%
Market Cap
$1.23B
Return on Invested Capital (ROIC)
1.12%
TTM Avg
-4.20%
3Y Avg
-6.46%
5Y Avg
-10.06%
Market Cap
$1.18B
Return on Invested Capital (ROIC)
1.32%
TTM Avg
13.41%
3Y Avg
0.51%
5Y Avg
-22.96%
Market Cap
$1.23B
Return on Invested Capital (ROIC)
-0.18%
TTM Avg
-25.12%
3Y Avg
-34.79%
5Y Avg
-34.79%
Market Cap
$1.24B
Return on Invested Capital (ROIC)
-40.32%
TTM Avg
-46.81%
3Y Avg
-44.75%
5Y Avg
-38.73%
Market Cap
$1.14B
Return on Invested Capital (ROIC)
-12.53%
TTM Avg
-48.13%
3Y Avg
-43.32%
5Y Avg
-40.54%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | $1.21B | -44.73% | -42.94% | -34.30% | -27.03% |
| Kardigan, Inc. (KARD)vs › | $1.21B | -57.11% | -57.11% | -57.11% | -57.11% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.20B | -52.44% | -96.82% | -100.85% | -77.97% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 9.48% | 1.29% | -3.62% | 0.10% |
| Cronos Group Inc. (CRON)vs › | $1.23B | 1.12% | -4.20% | -6.46% | -10.06% |
| MannKind Corporation (MNKD)vs › | $1.18B | 1.32% | 13.41% | 0.51% | -22.96% |
| Omada Health (OMDA)vs › | $1.23B | -0.18% | -25.12% | -34.79% | -34.79% |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | -40.32% | -46.81% | -44.75% | -38.73% |
| Nektar Therapeutics (NKTR)vs › | $1.14B | -12.53% | -48.13% | -43.32% | -40.54% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 5.93% | 9.95% | 11.37% | 9.31% |
ROIC
-44.7%
ROE
-42.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -44.73% |
| 2026-03-31 | -36.34% |
| 2025-12-31 | -50.10% |
| 2025-09-30 | -43.99% |
| 2025-06-30 | -39.53% |
| 2025-03-31 | -34.54% |
| 2024-12-31 | -29.86% |
| 2024-09-30 | -27.18% |
| 2024-06-30 | -24.98% |
| 2024-03-31 | -22.20% |
| 2023-12-31 | -37.97% |
| 2023-09-30 | -30.38% |
| 2023-06-30 | -24.12% |
| 2023-03-31 | -23.24% |
| 2022-12-31 | -22.62% |
| 2022-09-30 | -19.90% |
| 2022-06-30 | -16.63% |
| 2022-03-31 | -12.55% |
| 2021-12-31 | -8.67% |
| 2021-09-30 | -6.44% |
| 2021-06-30 | -11.55% |
| 2021-03-31 | -8.59% |
| 2020-12-31 | -65.69% |
